DUBLIN, Ireland, Nov. 02, 2017 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate in the following conferences in November:
Stifel 2017 Healthcare Conference
- Date: Tuesday, Nov. 14, 2017
- Presentation Time: 9:30 a.m. EST
- Location: New York, NY
Jefferies 2017 London Healthcare Conference
- Date: Thursday, Nov. 16, 2017
- Presentation Time: 2:40 p.m. GMT
- Location: London, United Kingdom
Piper Jaffray 29th Annual Healthcare Conference
- Date: Tuesday, Nov. 28, 2017
- Presentation Time: 11:30 a.m. EST
- Location: New York, NY
Bank of America/Merrill Lynch 2017 Leveraged Finance Conference
- Date: Wednesday, Nov. 29, 2017
- Presentation Time: 1:30 p.m. EST
- Location: Boca Raton, FL
Horizon Pharma’s presentations at these conferences will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcasts will be available for the events.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
Investors:
Tina Ventura
Senior Vice President,
Investor Relations
[email protected]
Ruth Venning
Executive Director,
Investor Relations
[email protected]
U.S. Media:
Geoff Curtis
Senior Vice President,
Corporate Affairs & Chief Communications Officer
[email protected]
Ireland Media:
Ray Gordon
Gordon MRM
[email protected]


Samsung Electronics Shares Jump on HBM4 Mass Production Report
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Explores AI Content Marketplace With Media Publishers
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Anta Sports Expands Global Footprint With Strategic Puma Stake
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 



